Cellectis bioresearch and Syngene announce partnership on the development of customized cell lines

Syngene and Cellectis Bioresearch_120111 final VE.pdf

The ETICS project, led by CYTOO in collaboration with Cellectis bioresearch and the CEA, to receive €7.6 million in funding from OSEO

110926_CBR_ETICS_EN-1.pdf

A collaboration to develop highly innovative kits for pharmaceutical research Paris, September 26, 2011 - CYTOO, a company that specializes in cell-based assays (Grenoble, France), has joined up with Cellectis bioresearch, the specialist in Genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), and the CEA, the French Alternative Energies and Atomic Energy Commission, to develop new high-value cell-based assays for drug development and toxicology.

Cellectis announces a ten-fold increase in nuclease production capacity in 2011 - Significantly expands potential for technology adoption worldwide

110907_production_EN.pdf

Paris (France), September 7, 2011 – Cellectis (Alternext: ALCLS), the French Genome engineering specialist, has announced that its Nuclease production capacity has increased ten fold in 2011, significantly reducing manufacturing costs. Industrialization of the Nuclease manufacturing gives Cellectis bioresearch, the Genome customization specialist and commercial subsidiary of Cellectis, the potential to supply the technology to approximately 300,000 academic and industrial research laboratories throughout the world.

Cellectis bioresearch grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock

110824_CBR_Recombinetics.pdf

Paris (France) and Minneapolis (USA), August 24, 2011 – Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis (Alternext: ALCLS), and Recombinetics, a specialist in biogenetics, announced today that they have entered a development and license agreement on the creation of transgenic large livestock. Recombinetics creates, in accordance with biosafety and animal well-being requirements, large livestock for agricultural, biomedical and bioproduction applications.